Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (6 quarters reported)
$171M in Q1 2025 → $196M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Sailpoint Inc | 22.4% | Unchanged | 3,000,000 | $43.9M |
| Birkenstock Holding PLC | 22.2% | New | 1,010,000 | $43.5M |
| Lineage Inc | 13.2% | Unchanged | 600,000 | $26M |
| BS Blackstone Secd Lending Fd | 12.1% | New | 1,000,818 | $23.7M |
| Goldman Sachs Bdc Inc | 10.6% | New | 2,192,392 | $20.8M |
| MS Morgan Stanley Direct Lendin | 8.5% | New | 1,103,814 | $16.7M |
| Blue Owl Capital Corporation | 6.7% | New | 1,200,244 | $13M |
| Navan Inc | 2.3% | Unchanged | 200,000 | $4.57M |
| Neumora Therapeutics Inc. | 1.8% | Unchanged | 2,124,143 | $3.61M |
| Figma Inc | 0.1% | New | 13,290 | $240K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 5 quarters.
quarter ended June 30, 2026 · filed July 23, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines Inc | Exited | −549,050 | −$53.4M | — |
| Birkenstock Holding PLC | New | +1,010,000 | +$43.5M | 22.2% |
| BS Blackstone Secd Lending Fd | New | +1,000,818 | +$23.7M | 12.1% |
| Goldman Sachs Bdc Inc | New | +2,192,392 | +$20.8M | 10.6% |
| MS Morgan Stanley Direct Lendin | New | +1,103,814 | +$16.7M | 8.5% |
| Blue Owl Capital Corporation | New | +1,200,244 | +$13M | 6.7% |
| Revolution Medicines Inc | Exited | −450,000 | −$806K | — |
| Figma Inc | New | +13,290 | +$240K | 0.1% |
quarter ended March 31, 2026 · filed April 16, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Revolution Medicines Inc | Trimmed | −1,647,150 | −$160M | 44.4% |
quarter ended December 31, 2025 · filed January 23, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| FT Figure Technology Solutio | Exited | −680,000 | −$24.7M | — |
| Navan Inc | New | +200,000 | +$3.42M | 1.3% |
quarter ended September 30, 2025 · filed November 20, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| FT Figure Technology Solutio | New | +680,000 | +$24.7M | 11.2% |
| Samsara Inc | Exited | −22,751 | −$905K | — |
quarter ended June 30, 2025 · filed July 17, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Samsara Inc | New | +22,751 | +$905K | 0.5% |
| Revolution Medicines Inc | New | +450,000 | +$118K | 0.1% |
Loading...
